![]() |
Case Report
1 MD, Radiologie Centrale, University Hospital Center Ibn Sina, Mohammed V University, Rabat, Morocco
2 Specialist, Radiologie Centrale, University Hospital Center Ibn Sina, Mohammed V University, Rabat, Morocco
3 Professor, Radiologie Centrale, University Hospital Center Ibn Sina, Mohammed V University, Rabat, Morocco
Address correspondence to:
Romeo Thierry Yehouenou Tessi
MD, Radiologie Centrale, University Hospital Center Ibn Sina, Mohammed V University, BP 6527, Rabat,
Morocco
Message to Corresponding Author
Article ID: 101310Z01RT2022
Primary synovial chondromatosis is characterized by a benign synovial proliferation associated with a metaplastic process. It remains a rare benign pathology of unknown cause. It evolves in three phases and the diagnosis is most often late. Imaging plays an essential role, particularly conventional radiology, computed tomography (CT)/arthroscan and magnetic resonance imaging (MRI). The imaging findings vary according to the stage. Synovial nodules and intra-articular foreign bodies are found. The knee is the most frequent localization. The treatment is surgical with the contribution of arthroscopy. We report the case of a 36-year-old woman who presented with gonalgia without any notion of trauma and who was diagnosed with primary chondromatosis by MRI with histologic confirmation. The recurrence rate remains low postoperatively and is often due to incomplete removal of synovial nodules and intra-articular foreign bodies.
Keywords: Chondromatosis, Knee, MRI, Primary
Primary (or idiopathic) synovial chondromatosis or Reichel–Jones–Henderson syndrome is characterized by the formation of multiple hyaline cartilage nodules under the synovial membrane [1],[2],[3]. These nodules may be released into the joint cavity and are then typically numerous, of approximately the same shape and size. Its etiology is poorly understood. It may be secondary or the result of a pre-existing pathology. This pathological condition is generally mono-articular and the knee is the most frequently affected joint. The evolution is most often progressive with a delay in diagnosis. It may occur less frequently in other joints, notably the hip, elbow, and shoulder [4]. Magnetic resonance imaging (MRI) allows a precise assessment of the local extension. The semiology is influenced by the subsynovial or free nature of the chondromas, and by their degree of mineralization and ossification. However, the diagnosis confirmation is made on histology. The treatment consists essentially in a synovectomy as complete as possible.
A 35-year-old female patient consulted for knee pain with a medial meniscal syndrome without any notion of trauma. The evolution was marked by a recurrent pain for two years with a moderate swelling of the knee. The patient didn't present a restriction of range motion An X-ray had been performed one year earlier without any abnormality. In view of the worsening of the symptomatology, a knee MRI was released in search of an etiology and revealed signal anomalies: Intra-articular nodular formations, Hoffa's fat, and the sub-quadricipital recessus, in T1 hyposignal, in T2 hypersignal with peripheral enhancement after injection, the most voluminous located behind the posterior cruciate ligament (PCL). Joint effusion and synovial enhancement are associated (Figure 1).
The diagnosis of primary synovial chondromatosis of the knee was evoked. Arthroscopy was performed and a histologic analysis found chondromas, which confirmed the diagnosis of chondromatosis (Figure 2).
Primary chondromatosis is a rare benign monoarticular pathology of the articular synovium characterized by synovial metaplasia of unknown origin. It is also known as Reichel–Jones–Henderson syndrome [4]. This synovial metaplasia and proliferation resulting in the formation of multiple cartilaginous foreign bodies of relatively similar size, not all of which are ossified. The term synovial chondromatosis is therefore preferred to primary synovial osteochondromatosis. It is distinguished from secondary synovial chondromatosis which is the result of a degenerative change in the joint. Secondary osteochondromatosis results from a pre-existing pathology [5]. The combination of osteoarthritis and osteocartilaginous nodules in the joint cavity corresponds exactly to this definition of secondary osteochondromatosis.
It affects men two to four times more than women, with a peak between the ages of 20 and 40 [4],[6]. Rare cases of familial association (2% cases) have been described in relation to collagen type 2 abnormalities, as described in Wagner–Stickler syndrome (hereditary arthro-ophthalmopathy) [7].
It classically evolves in three phases [8]:
The clinical signs frequently identified are pain (85–100%), joint swelling (42–58%), restriction of joint mobility (35–55%). There is a delay in diagnosis, estimated on an average at five years after the onset of symptoms [5],[6].
The majority of cases are located in the joints. The knee is the most frequent joint affected, with 50–65% of cases. Other locations are the hip, elbow, shoulder, and ankle. Occasionally the bursa and tendons may be affected [1],[2],[3].
Imaging reveals characteristic signs of the pathology, notably the presence of multiple intra-articular chondral bodies with “chondroid mineralization in the form of rings and arches, and extrinsic bone erosion on both sides of the bone.”
On conventional radiography, isolated non-specific synovial swelling, multiple intra-articular ring, and circle calcifications or osteochondromas, extrinsic erosions of the bone opposite or reactive hyperostosis may be seen [6],[8]. The joint space is normal or enlarged, which is suggestive of the diagnosis (interpositions of chondromas/articular cartilage hypertrophy may show abnormalities only in the calcification stage [6],[8].
On ultrasonography, they appear as round or oval nodules that are well defined and echogenic, with an effusion layer [7].
Computed tomography (CT) is the examination of choice for the demonstration of calcified intra-articular nodules and bone notches. Arthro-CT is described as the best examination for visualizing chondromas [5],[6].
The MRI appearance varies according to the stage of mineralization and ossification of the chondral bodies. There are three subtypes with a variable signal on MRI [4],[5],[6]:
Some differential diagnoses can be evoked in front of this picture namely [3],[5],[8]: secondary osteochondromatosis, arborescent lipoma (subquadricipital fatty swelling, without bone erosion with hypertrophy of synovial bangs with fatty signal in ± T2 hypersignal and enhancement of non-fatty areas, without effusion), synovial chondrosarcoma, pigmented villo-nodular synovitis (diffuse or localized with synovial thickening showing T2 hypointense areas with blooming on gradient echo images due to hemosiderin), synovial hemangioma (poorly systematized serpiginous lesion with extra-articular extension, no mass effect in hypo T1 hyper T2 iso + hypo T2 septa, intra-lesional fatty patches with heterogeneous intense enhancement).
The treatment of choice remains surgery. This treatment consists of removal of intra-articular foreign bodies. In case of active synovitis, a synovectomy can be performed [6].
The recurrence rate varies between 3% and 23% and is often associated with incomplete excision in most cases [4].
Arthroscopy with resection is becoming increasingly important in the management of arthroscopic injuries. Among other things, it reduces the mortality rate associated with the various postoperative rehabilitation procedures [4].
Primary chondromatosis of the knee remains a rare pathology. It presents as intra-articular foreign bodies originating from a metaplasia of the synovium. The cause remains unknown. Imaging plays an essential role in the diagnosis through the various means of exploration, in particular CT/arthroscan and MRI, which allow the diagnosis to be made with pathognomonic radiological signs. However, histological confirmation is sometimes necessary. The diagnosis is most often made late. The treatment of choice remains surgery by removal of the nodules. Arthroscopy is playing a major role in the management of the disease through the development of surgical techniques.
1.
Grimbizis GF, Gordts S, Di Spiezio Sardo A, et al. The ESHRE/ESGE consensus on the classification of female genital tract congenital anomalies. Hum Reprod 2013;28(8):2032–44. [CrossRef]
[Pubmed]
2.
Poncelet C, Aissaoui F. Uterine malformations and reproduction. [Article in French]. Gynecol Obstet Fertil 2007;35(9):821–5. [CrossRef]
[Pubmed]
3.
Yoo RE, Cho JY, Kim SY, Kim SH. A systematic approach to the magnetic resonance imaging-based differential diagnosis of congenital Müllerian duct anomalies and their mimics. Abdom Imaging 2015;40(1):192–206. [CrossRef]
[Pubmed]
4.
Brucker SY, Rall K, Campo R, Oppelt P, Isaacson K. Treatment of congenital malformations. Semin Reprod Med 2011;29(2):101–12. [CrossRef]
[Pubmed]
5.
The American Fertility Society classification of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, müllerian anomalies and intrauterine adhesions. Fertil Steril 1988;49(6):944–55. [CrossRef]
[Pubmed]
6.
Mordefroid M, Levaillant JM. Malformations utérines: Utérus bicorne ou cloisonné?: Critères de différenciation en IRM et échographie 3D. Imagerie de la Femme 2008;18(2):89–100. [CrossRef]
7.
Passos IMPE, Britto RL. Diagnosis and treatment of müllerian malformations. Taiwan J Obstet Gynecol 2020;59(2):183–8. [CrossRef]
[Pubmed]
8.
Rivas AG, Epelman M, Ellsworth PI, Podberesky DJ, Gould SW. Magnetic resonance imaging of Müllerian anomalies in girls: Concepts and controversies. Pediatr Radiol 2022;52(2):200–16. [CrossRef]
[Pubmed]
We thank the following individuals for their review of earlier drafts of the manuscript: Prof. Ittimade Nassar and Prof. Nabil Moatassim Billah, chief service and deputy chief service of Radiologie Centrale, University Hospital Center Ibn Sina, Mohammed V University, Rabat, Morocco.
Author ContributionsRomeo Thierry Yehouenou Tessi - Conception of the work, Design of the work, Acquisition of data, Analysis of data, Drafting the work, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Koudouhonon Rita Oze - Conception of the work, Design of the work, Acquisition of data, Analysis of data, Drafting the work, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Kaoutar Imrani - Conception of the work, Design of the work, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Khadija Ben El Hosni - Conception of the work, Design of the work, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Nabil Moatassim Billah - Conception of the work, Design of the work, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Ittimade Nassar - Conception of the work, Design of the work, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Guaranter of SubmissionThe corresponding author is the guarantor of submission.
Source of SupportNone
Consent StatementWritten informed consent was obtained from the patient for publication of this article.
Data AvailabilityAll relevant data are within the paper and its Supporting Information files.
Conflict of InterestAuthors declare no conflict of interest.
Copyright© 2022 Romeo Thierry Yehouenou Tessi et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.